APA (7th ed.) Citation

R, N., H, E., M, F., R, M., MS, F., S, A., . . . N, M. (2025). Omalizumab Efficacy in Chronic Rhinosinusitis Patients with Recurrent Nasal Polyps: An open-label, single-center, randomized, controlled study. The Annals of otology, rhinology, and laryngology, 134(9), 692. https://doi.org/10.1177/00034894251344426

Chicago Style (17th ed.) Citation

R, Noeiaghdam, Esmaeilzadeh H, Faramarzi M, Moshfeghinia R, Fallahi MS, Alyasin S, Nabavizadeh H, and Mortazavi N. "Omalizumab Efficacy in Chronic Rhinosinusitis Patients with Recurrent Nasal Polyps: An Open-label, Single-center, Randomized, Controlled Study." The Annals of Otology, Rhinology, and Laryngology 134, no. 9 (2025): 692. https://doi.org/10.1177/00034894251344426.

MLA (9th ed.) Citation

R, Noeiaghdam, et al. "Omalizumab Efficacy in Chronic Rhinosinusitis Patients with Recurrent Nasal Polyps: An Open-label, Single-center, Randomized, Controlled Study." The Annals of Otology, Rhinology, and Laryngology, vol. 134, no. 9, 2025, p. 692, https://doi.org/10.1177/00034894251344426.